S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TRAW Traws Pharma Inc

3.50

0.00 (0.00%)

Pre Market

Last Updated: 06:47:02

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Traws Pharma (NASDAQ:TRAW)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Traws Pharma Charts.

Traws Pharma (NASDAQ:TRAW)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Traws Pharma Charts.

Traws Pharma Inc News

Form 8-K - Current report
Wednesday 19 February 2025 (7 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 18 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 18 February 2025 (1 week ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 10 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 7 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Thursday 6 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 31 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 27 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 27 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 27 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Monday 27 January 2025 (4 weeks ago) • Edgar (US Regulatory)

More Traws Pharma Inc News Articles

Janus Henderson Income ETF

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions